Skip to main content
Medical information Clinical review pending

Infection Testing

SARS CoV2 Covid19 Total Antibodies Test

This test checks for total antibodies against SARS-CoV-2, the virus causing COVID-19. It helps assess your immune response, indicating potential past exposure or response to vaccination. Confirm with the laboratory before booking.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Serum (3 mL minimum, 1 mL preferred) collected in an SST tube.
Results
Typically available the next day. Confirm with the laboratory before booking.
Preparation
No specific patient preparation is required. Confirm with the laboratory before booking.
Test priceKSh 1,638

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the SARS CoV2 Covid19 Total Antibodies Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Individuals with symptoms suggestive of past COVID-19 infection.
  • ✓Individuals who have received COVID-19 vaccination.
  • ✓Individuals with known exposure to confirmed COVID-19 cases.
  • ✓Assessing potential immunity status.
  • ✓Population surveillance studies.
  • ✓Evaluating immune response post-infection or vaccination.
02

In plain language

What this test helps you understand

This test helps assess the presence of antibodies against SARS-CoV-2, indicating a past immune response to the virus, potentially from infection or vaccination. It can provide insights into exposure history.
The SARS CoV2 Covid19 Total Antibodies Test is a diagnostic tool used to assess your immune response to the COVID-19 virus. This test detects the presence of antibodies, which are proteins your immune system produces when it encounters the virus. Understanding your antibody status can provide insights into whether you have been exposed to the virus in the past.

This test measures the total amount of antibodies against SARS-CoV-2. It does not distinguish between antibodies developed from natural infection or vaccination. The presence of antibodies may suggest past exposure to the virus.

Individuals who may consider this test include those who have experienced symptoms consistent with COVID-19 and wish to confirm past infection, individuals who have received the COVID-19 vaccine and want to check their antibody response, or people who have been in contact with confirmed COVID-19 cases.

Taking this test can help determine if you have been exposed to the virus and provide insights into your immune response. It can assist in making informed decisions about your health and safety.

Results are typically available the next day. A positive result indicates the presence of antibodies, suggesting past exposure. A negative result indicates no detectable antibodies. It is important to discuss your results with a healthcare provider for accurate interpretation.

To perform the test, a blood sample is required. Please ensure you follow the specific instructions provided by the laboratory regarding sample collection and submission. A completed Covid-19 Antibody Test Form (Form 45) is required.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is required. Confirm with the laboratory before booking.
SampleSerum (3 mL minimum, 1 mL preferred) collected in an SST tube.
MethodologyConfirm with the laboratory before booking.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test measures total antibodies and does not differentiate between antibodies from infection or vaccination. Antibody levels can decline over time. A negative result does not rule out past infection or current infection. Results should be interpreted by a healthcare professional.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test detects total antibodies against the SARS-CoV-2 virus, indicating an immune response.
No, this test looks for antibodies, which are produced after infection or vaccination, not the virus itself. It does not diagnose an active infection.
The test can indicate the presence of antibodies, which may suggest a response to vaccination, but it doesn't measure the level of protection.
A positive result indicates that antibodies against SARS-CoV-2 were detected, suggesting past exposure to the virus.
A negative result means no detectable antibodies were found. This does not rule out past infection or current infection.
A blood sample (serum) is required for this test.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp